Colgate-Palmolive: Barclays Keeps Equal-Weight Rating, PT Down to $82
ByAinvest
Wednesday, Oct 1, 2025 11:23 am ET1min read
BCS--
Colgate-Palmolive reported earnings of $0.92 per share for the last quarter, surpassing analysts' expectations of $0.89, with revenue of $5.11 billion. The company also announced a quarterly dividend of $0.52 per share, to be paid on November 14th, representing an annualized yield of 2.6% [1].
The company's stock has seen increased interest from institutional investors and hedge funds. HB Wealth Management LLC, for instance, increased its stake by 7.1%, owning 81,142 shares worth approximately $7.37 million following the purchase of an additional 5,370 shares [1]. Several other hedge funds have also made significant changes to their positions in Colgate-Palmolive, with Westend Capital Management LLC raising its position by 111.1% and Cornerstone Planning Group LLC by 1,913.3% during the first quarter [1].
Analysts have mixed opinions on the stock. Wells Fargo & Company, JPMorgan Chase & Co., Morgan Stanley, and Citigroup have all revised their target prices, with Wells Fargo lowering its target to $80.00 and setting an underweight rating. Meanwhile, Barclays increased its price objective to $87.00 before lowering it to $82.00, maintaining an equal-weight rating [1].
Colgate-Palmolive has a market capitalization of $64.66 billion, a PE ratio of 22.47, and a price-to-earnings-growth ratio of 4.18. The company's stock has a beta of 0.35, indicating a lower volatility compared to the broader market [1].
As of September 12, 2025, Colgate-Palmolive's stock has been trading at $80.00, with a 50-day moving average of $83.89 and a 200-day moving average of $88.56. The company's debt-to-equity ratio is 6.79, and its current ratio is 0.89, indicating a solid financial position [1].
CL--
Colgate-Palmolive: Barclays Keeps Equal-Weight Rating, PT Down to $82
Barclays has maintained its equal-weight rating for Colgate-Palmolive (NYSE:CL) but has lowered its price target to $82. The investment bank's latest research report reflects the company's recent financial performance and market conditions [1].Colgate-Palmolive reported earnings of $0.92 per share for the last quarter, surpassing analysts' expectations of $0.89, with revenue of $5.11 billion. The company also announced a quarterly dividend of $0.52 per share, to be paid on November 14th, representing an annualized yield of 2.6% [1].
The company's stock has seen increased interest from institutional investors and hedge funds. HB Wealth Management LLC, for instance, increased its stake by 7.1%, owning 81,142 shares worth approximately $7.37 million following the purchase of an additional 5,370 shares [1]. Several other hedge funds have also made significant changes to their positions in Colgate-Palmolive, with Westend Capital Management LLC raising its position by 111.1% and Cornerstone Planning Group LLC by 1,913.3% during the first quarter [1].
Analysts have mixed opinions on the stock. Wells Fargo & Company, JPMorgan Chase & Co., Morgan Stanley, and Citigroup have all revised their target prices, with Wells Fargo lowering its target to $80.00 and setting an underweight rating. Meanwhile, Barclays increased its price objective to $87.00 before lowering it to $82.00, maintaining an equal-weight rating [1].
Colgate-Palmolive has a market capitalization of $64.66 billion, a PE ratio of 22.47, and a price-to-earnings-growth ratio of 4.18. The company's stock has a beta of 0.35, indicating a lower volatility compared to the broader market [1].
As of September 12, 2025, Colgate-Palmolive's stock has been trading at $80.00, with a 50-day moving average of $83.89 and a 200-day moving average of $88.56. The company's debt-to-equity ratio is 6.79, and its current ratio is 0.89, indicating a solid financial position [1].
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet